Your browser doesn't support javascript.
[SFBC working group "Biochemical markers of COVID-19"]. / Groupe de travail SFBC « Marqueurs biochimiques de COVID-19 ¼.
Beauvieux, Marie-Christine; Bérard, Annie M; Aimone-Gastin, Isabelle; Barbé, Françoise; Barguil, Yann; Collin-Chavagnac, Delphine; Delacour, Hervé; Delevallée, Céline; Nivet-Antoine, Valérie; Peoc'h, Katell; Poupon, Carole; Schmitt, François; Piéroni, Laurence; Sapin, Vincent.
  • Beauvieux MC; Service de biochimie, CHU de Bordeaux ; RMSB, UMR5536 CNRS Université Bordeaux, France.
  • Bérard AM; Service de biochimie, CHU de Bordeaux ; Université Bordeaux, France.
  • Aimone-Gastin I; Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy ; Université de Lorraine, Inserm UMR-S 1256, Faculté de médecine de Nancy, Vandoeuvre-lès-Nancy, France.
  • Barbé F; Laboratoire de biochimie-biologie moléculaire-nutrition-métabolisme, CHU de Nancy, France.
  • Barguil Y; UF de biochimie-toxicologie, Centre hospitalier territorial de Nouméa, Nouvelle-Calédonie, France.
  • Collin-Chavagnac D; Service de biochimie et biologie moléculaire, Groupement hospitalier Sud, Hospices civils de Lyon, France.
  • Delacour H; Hôpital d'instruction des armées Bégin, Département des laboratoires, Saint-Mandé, France.
  • Delevallée C; LBM Gen-Bio, Groupe Inovie, Clermont-Ferrand, France.
  • Nivet-Antoine V; DMU BioPhyGen, Hôpital Necker-Enfants Malades, AP-HP Centre, Laboratoire de biochimie générale ; UMRS1140, Faculté de pharmacie et Université de Paris, France.
  • Peoc'h K; HUPNVS, Hôpitaux Beaujon et Bichat, AP-HP Nord, Laboratoires de biochimie ; Université de Paris, France.
  • Poupon C; Laboratoire de biologie médicale, Centre hospitalier de Gonesse, France.
  • Schmitt F; Laboratoire de biologie médicale, Groupe hospitalier Bretagne Sud, Lorient, France.
  • Piéroni L; Département de biochimie et hormonologie, CHU de Montpellier ; DMU BioGeM, Hôpital Tenon, AP-HP Est, Département de biochimie, France.
  • Sapin V; Biochimie et génétique moléculaire, CHU Clermont-Ferrand ; UMR CNRS 6293, Inserm 1103, Université Clermont Auvergne, France.
Ann Biol Clin (Paris) ; 78(3): 269-277, 2020 06 01.
Article in French | MEDLINE | ID: covidwho-608309
ABSTRACT
The SARS-CoV-2 virus is responsible for an epidemic disease called COVID-19, which was initially evidenced in Wuhan, China, and spread very rapidly in China and around the world. In France, the first isolated case seems now to be reported in December 2019, stage 3 of the COVID-19 epidemic was triggered on March 14th, the start of the planned containment exit from May 11th. Healthcare services have faced a large influx of patients who may be beyond their capacity to receive and care, particularly in the Large-East and Ile-de-France regions. Some patients show an evolution of the disease never observed before with other coronaviruses and develop in a few days a very important inflammatory reaction, which can lead to death of patients. A working group of the French Society of Clinical Biology (SFBC) was set up with the objective of providing updated information on the current status of the biological prescriptions (focusing on biochemistry ones) and their evolution during the epidemic, and of analyzing the biological parameters associated with comorbidities and patient evolution in order to link biological results with medical events. The expanded working group covers all sectors of medical biology in France and extends to the French-speaking world hospital sectors (CHU and CH, Army Training Hospitals) and the private sector opening a field of view on the biological situation in establishments for dependent elderly, social establishments and clinical medical institutions. The purpose of this article is the presentation of this working group and its immediate and future actions.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Societies, Scientific / Biochemistry / Biomarkers / Coronavirus Infections / Clinical Laboratory Services / Betacoronavirus Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: French Journal: Ann Biol Clin (Paris) Year: 2020 Document Type: Article Affiliation country: Abc.2020.1563

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Societies, Scientific / Biochemistry / Biomarkers / Coronavirus Infections / Clinical Laboratory Services / Betacoronavirus Type of study: Diagnostic study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: French Journal: Ann Biol Clin (Paris) Year: 2020 Document Type: Article Affiliation country: Abc.2020.1563